Lazard Capital Starts Regeneron Pharma (REGN) at Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Nasdaq climbs as chip and AI-linked stocks bounce back
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Brent crude edges lower, even after Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| Regeneron (NASDAQ: REGN) | Delayed: 782.04 -8.7 (1.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $790.74 | 52 Week High | $592.36 | |||
| Open | $792.59 | 52 Week Low | $325.35 | |||
| Day High | $800.00 | P/E | 205.26 | |||
| Day Low | $780.83 | EPS | $3.81 | |||
| Volume | 489,580 | |||||
